Stents, Drug Eluting

bioresorbable stents, dissolving stents

A key prediction for interventional cardiology coming out of recent Transcatheter Cardiovascular Therapeutics (TCT) and American College of Cardiology (ACC) meetings is that bioresorbable stents will eventually replace conventional metallic stents...

Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval for the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System, the company's durable polymer ...

Cook Medical is again shipping its Zilver PTX drug-eluting peripheral stent to medical centers in the United States, Japan, Europe and other major markets. The shipments follow a brief period of unavailability due to a voluntary recall by Coo...

October 20, 2014 — Boston Scientific Corp. has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus Premier...
“Once patients have survived cancer, they don't die from cancer, they die from heart disease. Cardio-oncology is about making sure that doesn't happen," said...
A first-of-its kind study comparing the safety and efficacy of biodegradable polymer sirolimus-eluting stents (BP-SES) to durable polymer sirolimus-eluting...
Svelte Coronary DES DIRECT II Trial Six Month Results TCT 2014
Svelte Medical Systems reported that its drug-eluting coronary stent Integrated Delivery System (IDS) for percutaneous coronary intervention (PCI) met all...
cath lab stents drug eluting boston scientific promus premier
The 34 and 38 mm lengths of the Medtronic Resolute Integrity drug-eluting stent in diameters of 3, 3.5 and 4 mm with an indication for...
Cook Medical’s Zilver PTX drug-eluting peripheral stent is the first device of its kind on several fronts to go before FDA review...
The 32 and 38 mm lengths of Boston Scientific's Promus Element Plus everolimus-eluting platinum chromium (PtCr) coronary stent system, the...

Articles

bioresorbable stents, dissolving stents, Absorb stent, BVS
A key prediction for interventional cardiology coming out of recent Transcatheter Cardiovascular Therapeutics (TCT) and American College of Cardiology (ACC)...
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost-conscience environment of healthcare reform, there needs to...
cath lab drug-eluting balloons stents bare metal clinical trial study RIBS V
A clinical trial comparing the use of drug-eluting stents (DES) and drug-eluting balloons (DEB) in treating in-stent restenosis (...
stents drug eluting clinical trial study cath lab bioresorbable sort-out tct
A study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low...

Video Center

By Dave Fornell, editor of DAIC Magazine The key take away messages from the 26th annual...
4 weeks 16 hours ago
As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
7 weeks 2 days ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
13 weeks 18 hours ago
This webinar will discuss why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...